VOL. XCIV, NO. 247
* WIDE MOAT STOCKS COMPARISON *
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Sartorius Stedim Biotech S.A. vs Manhattan Associates, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Sartorius Stedim Biotech S.A.
DIM · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Sartorius Stedim Biotech S.A.'s moat claims, evidence, and risks.
View DIM analysisManhattan Associates, Inc.
MANH · The Nasdaq Stock Market LLC
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Manhattan Associates, Inc.'s moat claims, evidence, and risks.
View MANH analysisComparison highlights
- Moat score gap: Sartorius Stedim Biotech S.A. leads (80 / 100 vs 56 / 100 for Manhattan Associates, Inc.).
- Segment focus: Sartorius Stedim Biotech S.A. has 2 segments (75% in Sterile single-use bioprocessing consumables); Manhattan Associates, Inc. has 4 segments (50.4% in Professional services (implementation, consulting, training)).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Strong vs Weak.
- Moat breadth: Sartorius Stedim Biotech S.A. has 6 moat types across 3 domains; Manhattan Associates, Inc. has 7 across 1.
Primary market context
Sartorius Stedim Biotech S.A.
Sterile single-use bioprocessing consumables
Sterile single-use bioprocessing consumables (bags, filters, fluid management components)
Global
Biopharmaceutical manufacturers and CDMOs
Consumables supplier (single-use)
75%
Manhattan Associates, Inc.
Professional services (implementation, consulting, training)
Supply chain & omnichannel software implementation and consulting services
Global
Enterprises implementing or expanding supply chain/omnichannel systems
Implementation and advisory services provider
50.4%
Side-by-side metrics
Moat coverage
Shared moat types
Sartorius Stedim Biotech S.A. strengths
Manhattan Associates, Inc. strengths
Segment mix
Sartorius Stedim Biotech S.A. segments
Full profile >Sterile single-use bioprocessing consumables
Oligopoly
Bioprocessing equipment, systems, and software/services
Oligopoly
Manhattan Associates, Inc. segments
Full profile >Cloud subscriptions (Manhattan Active SaaS)
Oligopoly
Professional services (implementation, consulting, training)
Competitive
Maintenance and support (legacy perpetual licenses)
Monopoly
Perpetual licenses and hardware
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.